BioSignalIQ™

Know which accounts need your attention, and why.

BioSignalIQ™ tracks relevant company and market developments, shows why they matter commercially and helps teams focus on the accounts with the strongest timing and fit.

BioSignalIQ™ powered by Roots Analysis
Life Sciences MarketCommercial opportunity workspace
Illustrative workspace
Commercial overview

Three accounts moved closer to active review.

BioSignalIQ™ brings priority shifts, supporting signals and recommended focus into one decision view.

Priority account
Late-stage developerMultiple reinforcing signals
NOW-6M91
Latest signal
Manufacturing activity strengthenedFacility + clinical indicators
THIS WEEKSource-linked
Opportunity Outlook · Signal Intelligence · Priority Accounts · Dashboard Explore the workspace

From market developments to clear priorities.

01

Track developments

Monitor relevant company, clinical, regulatory, manufacturing, partnership and investment activity.

02

Assess relevance

Understand why each development may matter commercially.

03

Prioritize accounts

Compare opportunities using consistent scoring and timing.

04

Decide what to do next

See recommended next steps for the accounts that matter.

See BioSignalIQ™ in action.

Use the workspace navigation to review the opportunity outlook, signal records, ranked accounts and market dashboard.

Life Sciences MarketCommercial opportunity workspace
Illustrative data

Opportunity Outlook / Current review

Commercial Intelligence Command Center

Account priorities are connected to the developments, evidence, timing shifts and actions underneath them.

Review stateCurrentIllustrative view
Connected intelligence path
01Market development
02Verified signal
03Account context
04Priority + timing
05Action + history
Executive intelligenceCurrent review
Priority shiftThree accounts moved closer to active commercial review.Since previous review · 2 timing changes
Emerging signalManufacturing expansion activity is strengthening.Facility + hiring indicators
Attention requiredMultiple reinforcing signals detected across priority accounts.Review evidence before outreach
Workspace accessContinue into the BioSignalIQ™ workspace.

Explore how account priorities, signal intelligence and market analytics connect inside the product.

Priority accounts

Attention list

Dynamic ranking by relevance, timing and supporting evidence.

Evidence status shown per account
Latest intelligence

What changed

Chronological developments and their commercial interpretation.

Current
Evidence and interpretation remain separated
Explore furtherGo deeper into the intelligence behind each priority.

See how BioSignalIQ™ connects account movement, supporting signals and commercial timing. A guided demo walks through the complete evidence trail, scoring logic and account-level detail.

Schedule a Guided Demo
Analyst Lens · Why priorities changedSelected account · Late-stage developer
What changed

Facility activity was added to an already active late-stage program.

Why it matters

Reinforcing operational signals moved likely engagement timing into the near-term window.

What to watch

Facility scope, validation hiring and supplier-selection activity.

Priority change history

Account movement

APR67Baseline
MAY72Partnership ↑
JUN84Clinical ↑
SEP91Facility ↑
Recommended actions

Commercial next steps

Ordered by timing
Additional analytical depth

From visible priorities to deeper commercial context.

More scoring, evidence and action context is covered in the live walkthrough
Explore the intelligence beneath each priority.

Review full evidence, score history, commercial timing and recommended action using a workspace configured around your market.

Built around what your team sells.

BioSignalIQ™ evaluates each development against your offering, target accounts and commercial priorities, so the same signal can mean something different for a CDMO, CRO, equipment supplier or technology provider.

CDMO

Development

Late-stage clinical progress

Why it may matter

Potential process development, scale-up or manufacturing requirement.

CRO

Development

New clinical program or regulatory clearance

Why it may matter

Potential trial execution or specialist clinical-support requirement.

Equipment supplier

Development

New manufacturing facility or capacity expansion

Why it may matter

Potential process-equipment or facility-technology requirement.

Technology provider

Development

Technology transfer or workflow standardization

Why it may matter

Potential platform, validation or workflow-technology requirement.

See what is driving each account's priority.

Each priority combines evidence quality, signal strength, engagement timing, product / service fit and strategic fit. The components remain visible so teams can understand what moved and why.

Priority score breakdown

Every scoring component remains visible in the account record.

Evidence Quality18 / 20
Signal Strength23 / 25
Procurement / Engagement Timing17 / 20
Product / Service Fit17 / 20
Strategic Fit13 / 15
Total88 / 100 · High priority

Trace each signal back to the evidence.

BioSignalIQ™ keeps the source record and commercial interpretation distinct, so teams can verify what happened before acting on why it matters.

Source typeCompany announcementThis week · Example record
Example source
What happened

An example account announced a new biologics manufacturing site and planned operating capacity.

This is the factual development recorded from the source.

Why it may matter

The project may create new requirements across equipment, facility technology and manufacturing services.

This is the BioSignalIQ™ interpretation, shown separately from the source statement.

Source-backed factual recordSeparate commercial interpretation

See BioSignalIQ™ configured for your market.

Explore the workspace or schedule a guided demo to see how BioSignalIQ™ can be configured around your customers, products and commercial priorities.

Try BioSignalIQ™ Book a Demo A guided demo can be tailored to your market, account universe and commercial priorities.